In addition, a medium dose of Ganweikang tablet significantly reduced the increase in liver fibrosis indicators, including TGF-β1, Timp-1, Col1α1, and Col1α2 in NASH mice (Figure 5B). Here, COL1A2 is linked to metabolic dysfunction-associated steatohepatitis.